Ads
related to: warm autoimmune hemolytic anemia- Achieving Hemostasis
The Importance Of Balance
In Patients With Hemophilia.
- Stay Informed
Sign Up To Stay Connected With
Important Info On Hemophilia.
- Challenges And Impacts
People Living With Hemophilia
Have Burdens In Their Daily Lives.
- The Whole Experience
Talk About Your Whole Experience
With Your Healthcare Provider.
- Achieving Hemostasis
Search results
Autoimmune Hemolytic Anemia: Everything You Need to Know
Verywell Health via Yahoo News· 10 months agoAutoimmune hemolytic anemia (AIHA) is a rare autoimmune disorder that causes the body to mistake its...
Rigel Pharma Drops FDA Submission Plans For Expanded Use Of Its Lead Product
Benzinga via Yahoo Finance· 2 years agoRigel Pharmaceuticals Inc (NASDAQ: RIGL) received guidance from the FDA's review of its re-analysis...
If You're Thinking COVID Is Over... Here's What I Wish You Knew
HuffPost via Yahoo News· 1 year agoThe author on South Palm Beach in Florida during a weekday in the offseason in 2022. For most...
Rigel (RIGL) to Not Pursue the WAIHA Program, Cut Jobs
Zacks via Yahoo Finance· 2 years agoRigel (RIGL) decides to back out from the label expansion of fostamatinib for the treatment of...
Why Shares of Roivant Sciences Were Down Tuesday
Motley Fool· 1 year agoWhat happened Shares of Roivant Sciences (NASDAQ: ROIV) were down 13.26% in mid-morning trading on Tuesday. The biotech company, which specializes in...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 months agoThe first-quarter 2024 earnings season picked up pace this week, with Merck MRK, Sanofi SNY,...
4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023
Zacks via Yahoo Finance· 1 year agoThe drug and biotech sector is expected to see a favorable operating environment in 2023 despite...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2022 Earnings Call Transcript March 23, 2023 Operator:...
Immunovant (IMVT) Up More Than 20% in Past 3 Months: Here's Why
Zacks via Yahoo Finance· 2 years agoImmunovant's (IMVT) lead pipeline candidate, batoclimab, is being developed for treating myasthenia...
Reasons to Add Immunovant (IMVT) Stock to Your Portfolio Now
Zacks via Yahoo Finance· 2 years agoImmunovant (IMVT) is progressing well with its lead pipeline candidate batoclimab being developed...
